Crystal structure of carbapenemase OXA-58 from Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2135-2143

  Smith, Clyde A ^a   Antunes, Nuno Tiago ^b   Toth, Marta ^b   Vakulenko, Sergei B ^b  

^a SLAC NATIONAL ACCELERATOR LABORATORY   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; LYSINE; OXA 23; OXA 24; OXA 58; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ACINETOBACTER BAUMANNII; ACYLATION AND DEACYLATION; ARTICLE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME STRUCTURE; HYDROGEN BOND; HYDROPHOBICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; TAUTOMERIZATION;

ACINETOBACTER BAUMANNII; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CRYSTALLOGRAPHY, X-RAY; KINETICS;

EID: 84896947150     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01983-13     Document Type: Article

References (51)

1. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
2. Davies TA, Queenan AM, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C, Flamm RK. 2011. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and nonfermenters from the USA in 2007-09. J. Antimicrob. Chemother. 66:2298-2307. http://dx.doi.org/10.1093/jac/ dkr290.
3. Higgins PG, Dammhayn C, Hackel M, Seifert H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:233-238. http://dx.doi.org/10.1093/jac/dkp428.
4. Kallen AJ, Hidron AI, Patel J, Srinivasan A. 2010. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect. Control Hosp. Epidemiol. 31:528-531. http://dx.doi.org/10.1086/652152.
5. Kim YJ, Yoon JH, Kim SI, Hong KW, Kim JI, Choi JY, Yoon SK, You YK, Lee MD, Moon IS, Kim DG, Kang MW. 2011. High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant. Proc. 43:2397-2399. http://dx.doi.org/10.1016/j.transproceed.2011.06.011.
6. Livermore DM, Hill RL, Thomson H, Charlett A, Turton JF, Pike R, Patel BC, Manuel R, Gillespie S, Balakrishnan I, Barrett SP, Cumberland N, Twagira M. 2010. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int. J. Antimicrob. Agents 35:19-24. http://dx.doi.org/10.1016/j.ijantimicag.2009.09. 014.
7. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484. http://dx.doi.org/10.1128/AAC.01464-06. (Pubitemid 47519332)
8. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836. http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x. (Pubitemid 44151282)
9. Bou G, Oliver A, Martinez-Beltran J. 2000. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561. http://dx.doi.org/10.1128/AAC.44.6.1556-1561.2000. (Pubitemid 30340794)
10. Donald HM, Scaife W, Amyes SGB, Young HK. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199. http://dx.doi.org/10.1128/AAC.44.1.196-199.2000. (Pubitemid 30010698)
11. Heritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179. http://dx.doi.org/10. 1128/AAC.49.10.4174-4179.2005. (Pubitemid 41400961)
12. Paton R, Miles RS, Hood J, Amyes SGB. 1993. ARI-I: β-lactamase- mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88. http://dx.doi.org/10.1016/0924-8579(93)90045-7. (Pubitemid 23046364)
13. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208. http://dx.doi.org/10.1128/AAC.49.1.202-208.2005. (Pubitemid 40065794)
14. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
15. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458. http://dx.doi.org/10.1128/ CMR.00001-07.
16. Santillana E, Beceiro A, Bou G, Romero A. 2007. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 104:5354-5359. http://dx.doi.org/10. 1073/pnas.0607557104. (Pubitemid 47175684)
17. Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L, Tafi A, Nordmann P, Botta M, Rossolini GM, Mangani S. 2009. Crystal structure of the OXA-48 β-lactamase reveals mechanistic diversity among class D carbapenemases. Chem. Biol. 16:540-547. http://dx.doi.org/10.1016/j.chembiol. 2009.04.010.
18. Schneider KD, Ortega CJ, Renck NA, Bonomo RA, Powers RA, Leonard DA. 2011. Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem. J. Mol. Biol. 406:583-594. http://dx.doi.org/10.1016/j.jmb.2010.12.042.
19. Kaitany KC, Klinger NV, June CM, Ramey ME, Bonomo RA, Powers RA, Leonard DA. 2013. Structures of the class D carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam. Antimicrob. Agents Chemother. 53:4848-4855. http://dx.doi.org/10.1128/AAC.00762-13.
20. Smith CA, Antunes NT, Stewart NK, Toth M, Kumarasiri M, Chang M, Mobashery S, Vakulenko SB. 2013. Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii. Chem. Biol. 20:1107-1115. http://dx.doi.org/10.1016/j.chembiol.2013.07.015.
21. Golemi D, Maveyraud L, Vakulenko S, Tranier S, Ishiwata A, Kotra LP, Samama JP, Mobashery S. 2000. The first structural and mechanistic insights for class D β-lactamases: evidence for a novel catalytic process for turnover of β-lactam antibiotics. J. Am. Chem. Soc. 122:6132-6133. http://dx.doi.org/10.1021/ja0013881. (Pubitemid 30451128)
22. Paetzel M, Danel F, de Castro L, Mosimann SC, Page MGP, Strynadka NCJ. 2000. Crystal structure of the class D β-lactamase OXA-10. Nature Struct. Biol. 7:918-924. http://dx.doi.org/10.1038/79688.
23. Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W. 2001. Crystal structures of the class D β-lactamase OXA-13 in the native form and in complex with meropenem. J. Mol. Biol. 310:859-874. http://dx.doi.org/10.1006/jmbi.2001.4805. (Pubitemid 32695700)
24. Docquier JD, Benvenuti M, Calderone V, Giuliani F, Kapetis D, De Luca F, Rossolini GM, Mangani S. 2010. Crystal structure of the narrow-spectrum OXA-46 class D β-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates. Antimicrob. Agents Chemother. 54:2167-2174. http://dx.doi.org/10.1128/AAC.01517-09.
25. Petersen TN, Brunak S, von Heijne G, Nielsen H. 2011. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8:785-786. http://dx.doi.org/10.1038/nmeth.1701.
26. Matthews BW. 1968. Solvent contents of protein crystals. J. Mol. Biol. 33:491-497. http://dx.doi.org/10.1016/0022-2836(68)90205-2.
27. Kabsch W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26:795-800. http://dx.doi.org/10.1107/S0021889893005588.
28. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AGW, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67:235-242. http://dx.doi.org/10.1107/S0907444910045749.
29. Evans PR. 2006. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62:72-82. http://dx.doi.org/10.1107/S0907444905036693.
30. Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson EJ. 1999. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D Biol. Crystallogr. 55:247-255. http://dx.doi.org/10.1107/S090744499801405X. (Pubitemid 29053823)
31. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221. http://dx.doi.org/10.1107/S0907444909052925.
32. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. http://dx.doi.org/10.1107/S0907444904019158. (Pubitemid 41742764)
33. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242. http://dx.doi.org/10.1093/nar/28.1.235. (Pubitemid 30047768)
34. Krissinel E, Henrick K. 2004. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60:2256-2268. http://dx.doi.org/10.1107/S0907444904026460. (Pubitemid 41742778)
35. DeLano WL. 2002. The PyMOL molecular graphics system. Schrödinger, LLC, San Carlos, CA.
36. Sun T, Nukaga M, Mayama K, Braswell EH, Knox JR. 2003. Comparison of β-lactamases of classes A and D: 1.5-Å crystallographic structure of the class DOXA-1 oxacillinase. Protein Sci. 12:82-91. http://dx.doi.org/10.1110/ ps.0224303. (Pubitemid 36020137)
37. Schneider KD, Karpen ME, Bonomo RA, Leonard DA, Powers RA. 2009. The 1.4 Å crystal structure of the class D β-lactamase OXA-1 complexed with doripenem. Biochemistry 48:11840-11847. http://dx.doi.org/10.1021/bi901690r.
38. Banerjee S, Pieper U, Kapadia G, Pannell LK, Herzberg O. 1998. Role of the Ω-loop in the activity, substrate specificity, and structure of class A β-lactamase. Biochemistry 37:3286-3296. http://dx.doi.org/10.1021/ bi972127f. (Pubitemid 28125555)
39. Golemi D, Maveyraud L, Vakulenko S, Samama JP, Mobashery S. 2001. Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases. Proc. Natl. Acad. Sci. U. S. A. 98:14280-14285. http://dx.doi.org/10.1073/pnas.241442898. (Pubitemid 33121383)
40. Lamotte-Brasseur J, Dive G, Dideberg O, Charlier P, Frère JM, Ghuysen JM. 1991. Mechanism of acyl transfer by the class A serine β-lactamase of Streptomyces albus G. Biochem. J. 279:213-221.
41. Jelsch C, Mourey L, Masson JM, Samama JP. 1993. Crystal structure of Escherichia Coli TEM1 β-lactamase at 1.8 Å resolution. Proteins 16:364-383. http://dx.doi.org/10.1002/prot.340160406. (Pubitemid 23212483)
42. Strynadka NCJ, Adachi H, Jensen SE, Johns K, Sielecki A, Betzel C, Sutoh K, James MNG. 1992. Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution. Nature 359:700-705. http://dx.doi.org/10.1038/359700a0.
43. Smith CA, Caccamo M, Kantardjieff KA, Vakulenko S. 2007. Structure of GES-1 at atomic resolution: insights into the evolution of carbapenamase activity in the class A extended-spectrum β-lactamases. Acta Crystallogr. D Biol. Crystallogr. 63:982-992. http://dx.doi.org/10.1107/S0907444907036955. (Pubitemid 47346824)
44. Ke W, Pattanaik P, Bethel CR, Sheri A, Buynak JD, Bonomo RA, Van den Akker F. 2012. Structures of SHV-1 β-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation. PLoS One 7:e49035. http://dx.doi.org/10.1371/journal.pone.0049035.
45. Papp-Wallace KM, Taracila MA, Gatta JA, Ohuchi N, Bonomo RA, Nukaga M. 2013. Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. J. Biol. Chem. 288:19090-19102. http://dx.doi.org/10.1074/jbc.M113.458315.
46. Szarecka A, Lesnock KR, Ramirez-Mondragon CA, Nicholas HBJ, Wymore T. 2011. The class D β-lactamase family: residues governing the maintenance and diversity of function. Protein Eng. Des. Sel. 24:801-809. http://dx.doi.org/10.1093/protein/gzr041.
47. Walther-Rasmussen J, Hoiby N. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383. http://dx.doi.org/10.1093/jac/dki482. (Pubitemid 43240190)
48. Easton CJ, Knowles JR. 1982. Inhibition of the RTEM β-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid. Biochemistry 21:2857-2862. (Pubitemid 12067503)
49. Verma V, Testero SA, Amini K, Wei W, Liu J, Balachandran N, Monoharan T, Stynes S, Kotra LP, Golemi-Kotra D. 2011. Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii. J. Biol. Chem. 286:37292-37303. http://dx.doi.org/10.1074/jbc.M111.280115.
50. Karplus PA, Diederichs K. 2012. Linking crystallographic model and data quality. Science 336:1030-1033. http://dx.doi.org/10.1126/science.1218231.
51. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291. http://dx.doi.org/10.1107/S0021889892009944.